Moreover, there was no significant difference in overall survival between cKO mice without NK cell depletion treatment and NK cell-depleted WT mice (Supplementary Fig. 4B, D), suggesting that METTL3 deficiency largely abrogated the NK cell immunosurveillance of cancer. The gene discussed is METTL3; the disease is cancer.